Get an inside look. No lab coat required.
Vystar Details Preliminary Plans for RxAir Spin Off as Shareholder Dividend
Increased revenue from RxAir® UV light air purifiers that destroy more than 99.6% of airborne viruses and bacteria / Record revenue from Rotmans Furniture “Closing to Remodel” Sales Event / Increased gross profit by purchasing in larger quantities from fewer vendors
Vystar appoints Dr. Byron Novosad to Board of Directors
Vystar Partners with Corrie MacColl For Market Development, Manufacturing, Sales & Distribution of Vytex® Deproteinized Latex
Sanitize the Atmosphere in Your Home Office with the RxAir®400 Air Purifier
Ebola Model for RxAir 400
The RxAir disinfection unit is capable of inactivating or destroying 99.9% of the Ebola virus, as per the calculations presented herein
Residential Application Of The Portable Air Purification Unit
This analysis reveals that the system has a demonstrated ability to disinfect air and inactivate a wide range of pathogens.
Supplemental Air Purification For Hospitals And Health Care Facilities
This report reviews health care applications in which portable air purification units can be used to effectively control and contain
Chamber Test Analysis 99% OF BACTERIA REDUCTION
The results of this test confirm that the system appears to be effective in reducing bacteria counts in ambient atmospheres,
Prediction Of Virus Inactivation By The UV400
This report reviews the capability of the UV400 air disinfection unit to inactivate airborne viruses, based on laboratory test data
Chamber Test Analysis On Eco-RX Inc. Model 400 Air Purifier
The results of this test confirm that the Eco-Rx Model 400 appears to be effective in reducing bacteria counts in
Northeast Labs VOC and Odor Testing
The summary of results for the VOC testing conducted on the Uv Flu Tech units previously tested